Table 1.
Study Participant Characteristics at Baseline (n = 301)
| No. (%) | |
|---|---|
| Age, median (IQR), y | 40 (33–47) |
| Gender | … |
| Female | 154 (51.2) |
| Male | 147 (48.8) |
| More than a primary education | … |
| No | 220 (73.1) |
| Yes | 81 (26.9) |
| Married | … |
| No | 100 (33.3) |
| Yes | 200 (66.7) |
| Literacy (able to read full sentences) | … |
| No | 83 (27.6) |
| Yes | 218 (72.4) |
| AST value, median (IQR) | 32 (25–40) |
| ALT value, median (IQR) | 28 (22–38) |
| Self-reported ART adherence, prior 30 d | … |
| Excellent | 164 (54.5) |
| Very good | 81 (26.9) |
| Good | 51 (16.9) |
| Fair | 3 (1.0) |
| Poor | 1 (0.3) |
| Very poor | 1 (0.3) |
| Social Desirability Score, median (IQR) | 20 (18–22) |
| Self-reported alcohol use (any in the prior 3 mo) | … |
| No | 100 (33) |
| Yes | 201 (67) |
| Alcohol use (combination of self-report, Audit-C, and PEth) | … |
| Abstainer | 86 (28.6) |
| Any, not unhealthy | 66 (21.9) |
| Unhealthy | 149 (49.5) |
| Time since HIV diagnosis, median (IQR), y | 7.16 (5.05–11.40) |
| Undetectable viral load | … |
| No | 23 (7.9) |
| Yes | 269 (92) |
Abbreviations: ALT, alanine transaminase; ART, antiretroviral therapy; AST, aspartate transaminase; IQR, interquartile range.